Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
The Irish Medical Organisation has criticised planned HSE spending and recruitment controls, warning they could negatively affect patient care and frontline healthcare delivery.
The first authorised treatment for epidermolysis bullosa in Ireland has been made available, marking a major milestone for patients living with the painful rare skin condition.
Stakeholders at the AXIS Patient Access Conference in Dublin heard that Ireland must agree a clear operational roadmap to meet its 180-day reimbursement decision target.
University Hospital Galway has reached a major milestone in its redevelopment plan, with a design team appointed for two new ward blocks that will deliver 300 additional beds.
RCSI has launched Ireland’s first National Robotic Surgery Curriculum, supported by a €2.3m investment and designed to standardise robotic surgical training nationwide.
Researchers from across Ireland were honoured at the Irish Cancer Society Research Awards 2026, recognising advances in radiotherapy innovation and men’s cancer survivorship care.
RCSI has launched Ireland’s first National Robotic Surgery Curriculum, supported by a €2.3m investment and designed to standardise robotic surgical training nationwide.
Nordic Pharma has announced the European launch of Lacrifill®, a CE-marked canalicular gel designed to enhance tear film preservation in patients with dry eye disease.